Who Paid My Doc
Tiffany Matragas
Physician Assistant, Surgical Morristown, NJ Physician Assistant
NPI 1801081716 CMS profile 11014379
131 Madison Ave, Second Floor, Morristown, NJ 07960
General payments
$6,177
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Tiffany Matragas of Morristown, NJ is reported in the CMS Open Payments database as having received $6,177 across 360 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 96th percentile of Physician Assistant, Surgical profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
5 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $1,872 | 109 | |
| 2024 | General | $2,356 | 141 | |
| 2023 | General | $1,751 | 96 | |
| 2022 | General | $183 | 13 | |
| 2021 | General | $16 | 1 |
Beside peers
- Tiffany Matragas
- Physician Assistant, Surgical median
- Middle half of Physician Assistant, Surgical
- National median
In program year 2025, general payments to Tiffany Matragas were reported at $1,872. Among 8,152 Physician Assistant, Surgical profiles paid that year, the median was $146 and the middle half received between $51 and $385.
Show as a table
| Year | Tiffany Matragas | Physician Assistant, Surgical median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | — | — | $163 |
| 2020 | $0 | — | — | $114 |
| 2021 | $16 | $111 | $36–$285 | $132 |
| 2022 | $183 | $126 | $44–$350 | $149 |
| 2023 | $1,751 | $137 | $47–$355 | $160 |
| 2024 | $2,356 | $146 | $49–$384 | $164 |
| 2025 | $1,872 | $146 | $51–$385 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 23 billing codesPaid by Medicare
$99,205
Medicare patients
174
Services billed
12,364
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 75% | |
| Ischemic heart disease | 37% | |
| Osteoporosis | 37% | |
| Diabetes | 25% | |
| COPD | 25% | |
| Chronic kidney disease | 21% | |
| Depression | 19% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) J0717 | Office | 15 | 8,800 | $31,720 |
| Injection, denosumab, 1 mg J0897 | Office | 24 | 1,500 | $31,010 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 | Office | 38 | 103 | $528 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg J3420 | Office | 11 | 23 | $20 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Payments and prescribing
First 5 of 24 products · payments 2024Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.
| Product | Paid by | Related payments | Part D claims | Part B services |
|---|---|---|---|---|
| TREMFYA |
|
$774 | — | — |
| SIMPONI ARIA |
|
$365 | — | — |
| RINVOQ |
|
$318 | — | — |
| PURIFIED CORTROPHIN GEL |
|
$168 | — | — |
| SAPHNELO |
|
$78 | — | — |
A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.
See all 24 in the dashboard with a free accountRecords
360 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Related records
Physician Assistant, Surgical in New Jersey
Practitioners in the same specialty and state, ranked by reported value.
All Physician Assistant, Surgical
Everyone recorded under this specialty, nationwide.
Doctors in New Jersey
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.